For Justin Gover, CEO of British drugmaker GW Pharmaceuticals (NASDAQ: GWPH), society’s sudden embrace of cannabidiol (CBD), the other active ingredient found in the cannabis plant, is a trip—though CBD won’t make you trip. That’s caused by THC, or tetrahydrocannabinol, the cannabis component responsible for most of marijuana’s psychological effects.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,